Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-13 Sale |
2025-02-14 9:20 pm |
Axsome Therapeutics Inc. | AXSM | Pizzie Nick Chief Financial Officer |
15,000 | $130.1 | $1,951,530 | 42,675 (Indirect Direct) |
View |
| 2024-09-11 Sale |
2024-09-11 7:00 pm |
Axsome Therapeutics Inc. | AXSM | Saad Mark E Director |
11,016 | $91.31 | $1,005,871 | 10,302 (Indirect Direct) |
View |
| 2024-08-09 Sale |
2024-08-09 7:27 pm |
Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer |
47,739 | $84.26 | $4,022,488 | 5,783 (Direct) |
View |
| 2024-05-29 Sale |
2024-05-29 8:12 pm |
Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer |
7,910 | $74.31 | $587,813 | 5,783 (Direct) |
View |
| 2024-05-28 Sale |
2024-05-29 8:11 pm |
Axsome Therapeutics Inc. | AXSM | Coleman Mark Director |
10,497 | $75.17 | $789,107 | 14,600 (Direct) |
View |
| 2024-04-01 Sale |
2024-04-01 6:46 pm |
Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer |
24,662 | $77.24 | $1,904,942 | 0 (Direct) |
View |
| 2024-03-14 Sale |
2024-03-15 8:05 pm |
Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director |
32,323 | $69.84 | $2,257,449 | 167,668 (Indirect Direct) |
View |
| 2023-09-15 Sale |
2023-09-15 6:30 pm |
Axsome Therapeutics Inc. | AXSM | Coleman Mark Director |
29,588 | $75.18 | $2,224,430 | 428,953 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-21 Option Award |
2025-02-25 8:02 pm |
2025-02-21 2035-02-20 |
Axsome Therapeutics Inc. | AXSM | Mahony Susan Director |
1,312 | $0 | 1,312 (Direct) |
View |
| 2025-02-21 Option Award |
2025-02-25 8:00 pm |
2025-02-21 2035-02-20 |
Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director |
1,408 | $0 | 1,408 (Direct) |
View |
| 2025-02-21 Option Award |
2025-02-25 7:59 pm |
2025-02-21 2035-02-20 |
Axsome Therapeutics Inc. | AXSM | Saad Mark E Director |
1,494 | $0 | 1,494 (Direct) |
View |
| 2025-02-21 Option Award |
2025-02-25 7:57 pm |
N/A 2035-02-20 |
Axsome Therapeutics Inc. | AXSM | Maizel Ari Chief Commercial Officer |
23,296 | $0 | 23,296 (Direct) |
View |
| 2025-02-21 Option Award |
2025-02-25 7:56 pm |
N/A 2035-02-20 |
Axsome Therapeutics Inc. | AXSM | Murdock Hunter R. General Counsel |
23,296 | $0 | 23,296 (Direct) |
View |
| 2025-02-21 Option Award |
2025-02-25 7:54 pm |
N/A 2035-02-20 |
Axsome Therapeutics Inc. | AXSM | Pizzie Nick Chief Financial Officer |
28,362 | $0 | 28,362 (Direct) |
View |
| 2025-02-21 Option Award |
2025-02-25 7:53 pm |
N/A 2035-02-20 |
Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer |
32,413 | $0 | 32,413 (Direct) |
View |
| 2025-02-21 Option Award |
2025-02-25 7:51 pm |
N/A 2035-02-20 |
Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner |
86,105 | $0 | 86,105 (Direct) |
View |
| 2025-02-13 Exercise |
2025-02-14 9:20 pm |
2019-05-16 2028-05-16 |
Axsome Therapeutics Inc. | AXSM | Pizzie Nick Chief Financial Officer |
15,000 | $3.5 | 42,675 (Direct) |
View |
| 2025-01-03 Exercise |
2025-01-06 4:06 pm |
2016-11-19 2025-11-19 |
Axsome Therapeutics Inc. | AXSM | Coleman Mark Director |
9,127 | $0 | 460,993 (Direct) |
View |
| 2025-01-03 Exercise |
2025-01-06 4:06 pm |
N/A N/A |
Axsome Therapeutics Inc. | AXSM | Coleman Mark Director |
9,127 | $9 | 460,993 (Direct) |
View |
| 2024-11-19 Exercise |
2024-11-20 4:30 pm |
2015-06-29 2025-06-29 |
Axsome Therapeutics Inc. | AXSM | Coleman Mark Director |
33,410 | $0 | 451,866 (Direct) |
View |
| 2024-11-19 Exercise |
2024-11-20 4:30 pm |
N/A N/A |
Axsome Therapeutics Inc. | AXSM | Coleman Mark Director |
33,410 | $5.94 | 451,866 (Direct) |
View |
Ownership |
2024-10-24 6:23 pm |
N/A 2033-09-25 |
Axsome Therapeutics Inc. | AXSM | Maizel Ari Chief Commercial Officer |
0 | $0 | 91,561 (Direct) |
View |
| 2024-09-11 Exercise |
2024-09-11 7:00 pm |
N/A N/A |
Axsome Therapeutics Inc. | AXSM | Saad Mark E Director |
11,016 | $3.67 | 10,302 (Direct) |
View |
| 2024-09-11 Exercise |
2024-09-11 7:00 pm |
2015-09-16 2024-09-16 |
Axsome Therapeutics Inc. | AXSM | Saad Mark E Director |
11,016 | $0 | 10,302 (Direct) |
View |
| 2024-08-09 Exercise |
2024-08-09 7:27 pm |
2015-12-29 2024-12-29 |
Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer |
47,739 | $0 | 5,783 (Direct) |
View |
| 2024-08-09 Exercise |
2024-08-09 7:27 pm |
N/A N/A |
Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer |
47,739 | $4.04 | 5,783 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-11 4:32 pm |
2025-06-07 2034-06-07 |
Axsome Therapeutics Inc. | AXSM | Mahony Susan Director |
5,799 | $0 | 5,799 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-11 4:31 pm |
2025-06-07 2034-06-07 |
Axsome Therapeutics Inc. | AXSM | Coleman Mark Director |
5,799 | $0 | 5,799 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-11 4:31 pm |
2025-06-07 2034-06-07 |
Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director |
5,799 | $0 | 5,799 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-11 4:30 pm |
2025-06-07 2034-06-07 |
Axsome Therapeutics Inc. | AXSM | Saad Mark E Director |
5,799 | $0 | 5,799 (Direct) |
View |
| 2024-05-29 Exercise |
2024-05-29 8:12 pm |
2015-08-15 2024-06-18 |
Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer |
13,693 | $0 | 5,783 (Direct) |
View |
| 2024-05-29 Exercise |
2024-05-29 8:12 pm |
N/A N/A |
Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer |
13,693 | $1.3 | 5,783 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-01 6:46 pm |
2014-10-03 2024-04-03 |
Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer |
24,662 | $0 | 0 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-01 6:46 pm |
N/A N/A |
Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer |
24,662 | $1.3 | 0 (Direct) |
View |
| 2024-03-14 Exercise |
2024-03-15 8:05 pm |
N/A N/A |
Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director |
13,000 | $22.03 | 167,668 (Direct) |
View |
| 2024-03-14 Exercise |
2024-03-15 8:05 pm |
2020-06-07 2029-06-07 |
Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director |
32,323 | $0 | 167,668 (Direct) |
View |
| 2024-03-14 Exercise |
2024-03-15 8:05 pm |
N/A N/A |
Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director |
16,976 | $25.53 | 167,668 (Direct) |
View |
| 2024-03-15 Exercise |
2024-03-15 8:05 pm |
N/A N/A |
Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director |
2,347 | $29.91 | 167,668 (Direct) |
View |
| 2024-02-27 Option Award |
2024-02-29 6:34 pm |
2024-02-27 2034-02-26 |
Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director |
1,425 | $0 | 1,425 (Direct) |
View |
| 2024-02-27 Option Award |
2024-02-29 6:34 pm |
2024-02-27 2034-02-26 |
Axsome Therapeutics Inc. | AXSM | Saad Mark E Director |
1,519 | $0 | 1,519 (Direct) |
View |
| 2024-02-27 Option Award |
2024-02-29 6:34 pm |
N/A 2034-02-26 |
Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. CHIEF OPERATING OFFICER |
50,852 | $0 | 50,852 (Direct) |
View |
| 2024-02-27 Option Award |
2024-02-29 6:25 pm |
N/A 2034-02-26 |
Axsome Therapeutics Inc. | AXSM | Pizzie Nick CHIEF FINANCIAL OFFICER |
44,496 | $0 | 44,496 (Direct) |
View |
| 2024-02-27 Option Award |
2024-02-29 6:20 pm |
N/A 2034-02-26 |
Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER 10% Owner |
135,078 | $0 | 135,078 (Direct) |
View |
| 2024-02-27 Option Award |
2024-02-29 6:18 pm |
2024-02-27 2034-02-26 |
Axsome Therapeutics Inc. | AXSM | Mahony Susan Director |
191 | $0 | 191 (Direct) |
View |
| 2024-02-27 Option Award |
2024-02-29 5:39 pm |
N/A 2034-02-26 |
Axsome Therapeutics Inc. | AXSM | Murdock Hunter R. General Counsel |
36,549 | $0 | 36,549 (Direct) |
View |
| 2023-10-10 Option Award |
2023-10-12 8:33 pm |
2024-10-10 2033-10-10 |
Axsome Therapeutics Inc. | AXSM | Mahony Susan Director |
7,375 | $0 | 7,375 (Direct) |
View |
| 2023-09-15 Exercise |
2023-09-15 6:30 pm |
N/A N/A |
Axsome Therapeutics Inc. | AXSM | Coleman Mark Director |
11,016 | $3.67 | 428,953 (Direct) |
View |
| 2023-09-15 Exercise |
2023-09-15 6:30 pm |
2015-09-16 2024-09-16 |
Axsome Therapeutics Inc. | AXSM | Coleman Mark Director |
11,016 | $0 | 428,953 (Direct) |
View |
| 2023-06-02 Option Award |
2023-06-06 6:22 pm |
2024-06-02 2033-06-02 |
Axsome Therapeutics Inc. | AXSM | Saad Mark E Director |
5,681 | $0 | 5,681 (Direct) |
View |
| 2023-06-02 Option Award |
2023-06-06 6:22 pm |
2024-06-02 2033-06-02 |
Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director |
5,681 | $0 | 5,681 (Direct) |
View |
| 2023-06-02 Option Award |
2023-06-06 6:21 pm |
2024-06-02 2033-06-02 |
Axsome Therapeutics Inc. | AXSM | Coleman Mark Director |
5,681 | $0 | 5,681 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 6:16 pm |
N/A 2033-03-01 |
Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER 10% Owner |
172,432 | $0 | 172,432 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 6:15 pm |
N/A 2033-03-01 |
Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. CHIEF OPERATING OFFICER |
64,915 | $0 | 64,915 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 6:14 pm |
N/A 2033-03-01 |
Axsome Therapeutics Inc. | AXSM | Pizzie Nick CHIEF FINANCIAL OFFICER |
56,800 | $0 | 56,800 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 6:14 pm |
N/A 2033-03-01 |
Axsome Therapeutics Inc. | AXSM | Murdock Hunter R. General Counsel |
46,656 | $0 | 46,656 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 6:13 pm |
2023-03-02 2033-03-01 |
Axsome Therapeutics Inc. | AXSM | Coleman Mark Director |
2,870 | $0 | 2,870 (Direct) |
View |